Article

A Long-term Progression-free Survival with Glioblastoma Patient Harboring MSH6 Pathogenic Germline Mutation: A Case Report

2025-02-03

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Lynch syndrome (LS) is a cancer syndrome caused by germline mutations in DNA mismatch repair genes. Patients with Lynch syndrome have higher risk of brain tumors, predominantly high-grade gliomas. LS-related gliomas have poor overall survival. <bold>Case presentation</bold> We present a case of a31-year-old male patient with a frontal lesion by magnetic resonance...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 47865c50-2bb6-5f93-b5e7-408a95e4c72f
DOI: 10.21203/rs.3.rs-5741696/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Long-term Progression-free Survival with Glioblastoma Patient Harboring MSH6 Pathogenic Germline Mutation: A Case ReportDOI 10.21203/rs.3.rs-5741696/v1Read

Clinicopathologic, molecular and tumor immune microenvironment features of mismatch repair-deficient glioblastomas in Lynch syndrome: a multicenter study of 29 cases with therapeutic implications.Semantic proximity Read

Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors.Semantic proximity Read

A high frequency of MSH6 G268A polymorphism and survival association in glioblastoma.Semantic proximity Read

Whole genome sequencing-based analysis of genetic predisposition to adult glioblastomaSemantic proximity Read

Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndromeSemantic proximity Read

An unusual tumor spectrum in Lynch syndrome caused by MSH6 mutationSemantic proximity Read

Unique Genetic and Epigenetic Alterations in Glioblastoma Long-Term Survivors: Insights From Two Clinical Cases.Semantic proximity Read

[Constitutional mismatch repair-deficiency syndrome (CMMR-D) - a case report of a family with biallelic MSH6 mutation].Semantic proximity Read

High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient.Semantic proximity Read

Pembrolizumab alters the tumor immune landscape in a patient with dMMR glioblastomaSemantic proximity Read

MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.Semantic proximity Read

High-grade brain tumors in siblings with biallelic MSH6 mutations.Semantic proximity Read